UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation
Open Access
- 15 May 2018
- journal article
- research article
- Published by Springer Nature in BMC Biotechnology
- Vol. 18 (1) , 28
Abstract
Nonsense mutations promote premature translational termination, introducing stop codons within the coding region of mRNAs and causing inherited diseases, including thalassemia. For instance, in β039 thalassemia the CAG (glutamine) codon is mutated to the UAG stop codon, leading to premature translation termination and to mRNA destabilization through the well described NMD (nonsense-mediated mRNA decay). In order to develop an approach facilitating translation and, therefore, protection from NMD, ribosomal read-through molecules, such as aminoglycoside antibiotics, have been tested on mRNAs carrying premature stop codons. These findings have introduced new hopes for the development of a pharmacological approach to the β039 thalassemia therapy. While several strategies, designed to enhance translational read-through, have been reported to inhibit NMD efficiency concomitantly, experimental tools for systematic analysis of mammalian NMD inhibition by translational read-through are lacking. We developed a human cellular model of the β039 thalassemia mutation with UPF-1 suppressed and showing a partial NMD suppression. This novel cellular model could be used for the screening of molecules exhibiting preferential read-through activity allowing a great rescue of the mutated transcripts.Keywords
This publication has 26 references indexed in Scilit:
- Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense SuppressionPLOS ONE, 2013
- Development of K562 cell clones expressing β‐globin mRNA carrying the β039 thalassaemia mutation for the screening of correctors of stop‐codon mutationsBiotechnology and Applied Biochemistry, 2009
- Production of β‐globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patientsAmerican Journal of Hematology, 2009
- Introducing sense into nonsense in treatments of human genetic diseasesTrends in Genetics, 2008
- Effects of rapamycin on accumulation of α‐, β‐ and γ‐globin mRNAs in erythroid precursor cells from β‐thalassaemia patientsEuropean Journal of Haematology, 2006
- β-globin cluster haplotypes in normal individuals and β039-thalassemia carriers from Sardinia, ItalyAmerican Journal of Human Biology, 2005
- Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cellsBlood, 2003
- Correction of genetic disease by making sense from nonsenseJournal of Clinical Investigation, 1999
- beta zero thalassemia in Sardinia is caused by a nonsense mutation.Journal of Clinical Investigation, 1981
- K562 human leukaemic cells synthesise embryonic haemoglobin in response to haeminNature, 1979